COVID-19 is a respiratory tract infection caused by the new coronavirus SARS-COV2 that can be complicated by acute distress respiratory syndrome and multiorgan failure. In light of the high rate of mortality associated with COVID-19, pharmacological and non-pharmacological strategies to prevent the infection are currently being tested. Among non-pharmacological preventive measures, vaccines represent one of the main resources for public health. It has been suggested that Bacille Calmette-Guérin (BCG) vaccine may protect individuals against infection from COVID-19 virus, and two clinical trials addressing this question are underway. Here, we report the case of a 32-year-old woman, vaccinated with BCG when she was 1 year old, who was diagnosed with apical tuberculous pneumonia of the right lung along with COVID 19 pneumonia.

Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG). Case Report / Luciani, Michelangelo; Bentivegna, Enrico; Spuntarelli, Valerio; AMORIELLO LAMBERTI, Piera; Guerritore, Ludovica; Chiappino, Dario; Nalli, Gabriele; Proietta, Maria; DEL PORTO, Flavia; Martelletti, Paolo; Sesti, Giorgio. - In: SN COMPREHENSIVE CLINICAL MEDICINE. - ISSN 2523-8973. - Oct 17(2020), pp. 1-4. [10.1007/s42399-020-00601-9]

Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG). Case Report

Michelangelo Luciani
;
Enrico Bentivegna;Valerio Spuntarelli;Piera Amoriello Lamberti;Ludovica Guerritore;Dario Chiappino;Gabriele Nalli;Maria Proietta;Flavia Del Porto;Paolo Martelletti;Giorgio Sesti
2020

Abstract

COVID-19 is a respiratory tract infection caused by the new coronavirus SARS-COV2 that can be complicated by acute distress respiratory syndrome and multiorgan failure. In light of the high rate of mortality associated with COVID-19, pharmacological and non-pharmacological strategies to prevent the infection are currently being tested. Among non-pharmacological preventive measures, vaccines represent one of the main resources for public health. It has been suggested that Bacille Calmette-Guérin (BCG) vaccine may protect individuals against infection from COVID-19 virus, and two clinical trials addressing this question are underway. Here, we report the case of a 32-year-old woman, vaccinated with BCG when she was 1 year old, who was diagnosed with apical tuberculous pneumonia of the right lung along with COVID 19 pneumonia.
2020
covid-19; sars-cov-2; tuberculosis; pneumonia; immunity; bcg
01 Pubblicazione su rivista::01a Articolo in rivista
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG). Case Report / Luciani, Michelangelo; Bentivegna, Enrico; Spuntarelli, Valerio; AMORIELLO LAMBERTI, Piera; Guerritore, Ludovica; Chiappino, Dario; Nalli, Gabriele; Proietta, Maria; DEL PORTO, Flavia; Martelletti, Paolo; Sesti, Giorgio. - In: SN COMPREHENSIVE CLINICAL MEDICINE. - ISSN 2523-8973. - Oct 17(2020), pp. 1-4. [10.1007/s42399-020-00601-9]
File allegati a questo prodotto
File Dimensione Formato  
Luciani_Coinfection_2020.pdf

accesso aperto

Note: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568690/ l’articolo è reso disponibile per la durata della dichiarazione dell'Organizzazione mondiale della sanità (OMS) di COVID-19 come pandemia globale.
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 544.47 kB
Formato Adobe PDF
544.47 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1453435
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact